Biolabs, a new biotech incubator located in the historic Hôtel Dieu, was inaugurated on 6 July 2023. As a founding
Category: General
Ipsen’s 2022 Integrated Annual Report now available
2022 was a year of focus, momentum and growth at Ipsen. Learn about the progress we made and download the
Ipsen anti-corruption system certification renewed in 2022
In December 2021, Ipsen received ISO 37001 certification for its anti-corruption management systems by Eurocompliance, a certification organization dedicated to
Ipsen becomes a founding sponsor of the second Biolabs innovation hub in Europe at Hopital Hotel Dieu, AP-HP
Ipsen announces that it becomes a founding sponsor of the second Biolabs innovation brain hub in Europe at Hopital Hotel
Epizyme welcome to Ipsen
Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.
A message from CEO David Loew
Hear what CEO David Loew has to say about our H1 2022 results.
How to transform the medical organization in specialty care to drive best-in-class patient value
By Steven Hildemann, MD, PhD, EVP, Chiel Medical Officer Medical affairs play a central role at Ipsen, where our strategy
Ukraine situation: What Ipsen is doing
Latest Update: March 29, 2022 The on-going tragedy in Ukraine is profoundly worrying, and our thoughts are with everyone impacted.
Our pledge: summaries in plain language for all journal publications
Today, we are broadening our commitment to providing everyone with the opportunity to read and understand our research. From July
Ipsen continues to strengthen early oncology pipeline with Queen’s University Belfast collaboration and licensing agreement.
Today we are pleased to announce a partnership with the Queen’s University of Belfast (QUB), securing rights to a preclinical